Meta AnalysisID 6976

冬虫夏草治疗慢性阻塞性肺疾病:基于啮齿类动物数据的系统评价与Meta分析

CRD42023428825

Does supplementation of cordyceps or its related artificial substitutes, such as Bailing capsules, have a preventive or improving effect on chronic obstructive pulmonary disease ( COPD ) ? Population (P): animal models o

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
6976
Evidence Id
15534
Core Evidence Id
15534
Source Meta Analysis Id
6957
Herb2 Meta Analysis Id
HBMA006957
Crd Id
CRD42023428825
Title
Cordyceps in the treatment of Chronic obstructive pulmonary disease (COPD) : a systematic review and meta-analysis of rodent data
Review Question
Does supplementation of cordyceps or its related artificial substitutes, such as Bailing capsules, have a preventive or improving effect on chronic obstructive pulmonary disease ( COPD ) ? Population (P): animal models of COPD Intervention (I): cordyceps and its substitutes supplemented diet Comparison (C): COPD group Outcomes (O): changes of respiratory function and inflammatory markers Context and rationale Chronic Obstructive Pulmonary Disease (COPD) is a common disease of the respiratory system, characterized by persistent airfow limitation. COPD is caused by the continued chronic infammation when airways are exposed to cigarette smoke, noxious particles, or smoke from biomass fuels. It has been a major cause of chronic morbidity and mortality throughout the world, especially in developing countries. Chronic obstructive pulmonary disease ( COPD ) is a widespread disease that has become the third leading cause of death in humans. In preclinical studies, COPD animal model is an effective way to solve this worldwide problem. Finding effective interventions for the COPD model is of great significance for the treatment of this disease. Cordyceps is a traditional Chinese drug that can improve lung functionality when used to treat COPD patients. By systematically collating published preclinical data, this study aims to systematically evaluate the preclinical efficacy of cordyceps and its substitutes in the treatment of COPD, providing a reference and basis for the development and application of cordyceps related preparations.
Study Type Included
Inclusion criteria: Controlled studies with a separate control group Exclusion criteria: Case studies
Condition Being Studied
Participant
Animal
Inclusion criteria: Species: all related species at all available studies, such as Wister rats, SD rats, and Balb / c mice in rodents. Sex: male and female. Disease model: cigarette smoke or cigarette smoke combined with LPS-induced COPD. Exclusion criteria: Species are humans, not animals
Human Disease Modelled
Chronic Obstructive Pulmonary Disease (COPD)
Intervention
Inclusion criteria: Cordyceps and its substitutes (Jinshuibao capsule, Bailing capsule, Zhiling capsule, and artificial cordyceps mycelium) Exclusion criteria: Interventions are not cordyceps or cordyceps substitutes, such as Cordyceps militaris.
Comparator Control
Inclusion criteria: Vehicle-treated control animals Exclusion criteria: No treatment
Main Outcome
Outcome Measure
Inclusion criteria: The major outcomes include spirometric parameters (FEV1% predicted or FEV1/FVC ratio), six-minute walk distance (6MWD), St. George's Respiratory Questionnaire (SGRQ) total score, and frequency of exacerbation. The minor outcomes include immunologic function, effective rate, and blood gas measurement. Exclusion criteria: Mortality
Additional Outcome
Study Method
Keyword
Animals; Biomass; Cigarette Smoking; Cordyceps; Developing Countries; Dietary Supplements; Humans; Morbidity; Pulmonary Disease, Chronic Obstructive; Rodentia; bailing capsules
Contact
Yong Li [email protected]
Organisational Affiliation
Chengdu university of traditional chinese medicine https://www.cdutcm.edu.cn/
Funding Source
National Natural Science Foundation of China Grant number(s) 81872959
Other Selection Criteria
Reviews, case reports, conferences, nonRCTs, and studies involving animals will be excluded.
Final Publication
Same Topic Review
Published Protocol
Review Type
Pre-clinical animal intervention review
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2023-05-23
Registration Date
2023-09-06
Anticipated Start Date
2023-05-23
Anticipated Completion Date
2023-12-24
Title Cn
冬虫夏草治疗慢性阻塞性肺疾病:基于啮齿类动物数据的系统评价与Meta分析
Title En
Cordyceps in the treatment of Chronic obstructive pulmonary disease (COPD) : a systematic review and meta-analysis of rodent data
Bilingual Status
complete